2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2018 | |
Criterium: | Position: |
Overall Score: | 300-400 |
Total Project Funding per Partner: | 400-500 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | 100-200 |
Total number of projects: 4
As coordinator: 1
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0.33*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2023 | 0 | 10.607.311 | 198.938 | 1 | ||
2022 | 0 | 4.592.115 | 1.736.624 | 1 | ||
2019 | 0 | 14.994.551 | 431.979 | 1 | ||
2018 | 12.436.859 | 0 | 2.974.437 | 1 |
Total number of partners: 80
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 77
Frequent / Rare Partner Ratio: 0.04
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2023-01-01 | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe | EUonQoL | participant | 10.607.311 | 27 |
2022-10-01 | PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification | PRE-ACT | participant | 4.592.115 | 10 |
2019-01-01 | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | ONCOBIOME | participant | 14.994.551 | 18 |
2018-01-01 | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70 | MyPeBS | coordinator | 12.436.859 | 29 |